• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆固醇相互作用直接增强囊性纤维化跨膜电导调节剂(CFTR)的固有活性。

Cholesterol Interaction Directly Enhances Intrinsic Activity of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).

机构信息

Programme in Molecular Medicine, Research Institute, Hospital for Sick Children, Toronto, ON M5G0A4, Canada.

Department of Biochemistry, University of Toronto, Toronto, ON M5G0A4, Canada.

出版信息

Cells. 2019 Jul 31;8(8):804. doi: 10.3390/cells8080804.

DOI:10.3390/cells8080804
PMID:31370288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6721619/
Abstract

The recent cryo-electron microscopy structures of zebrafish and the human cystic fibrosis transmembrane conductance regulator (CFTR) provided unprecedented insights into putative mechanisms underlying gating of its anion channel activity. Interestingly, despite predictions based on channel activity measurements in biological membranes, the structure of the detergent purified, phosphorylated, and ATP-bound human CFTR protein did not reveal a stably open conduction pathway. This study tested the hypothesis that the functional properties of the detergent solubilized CFTR protein used for structural determinations are different from those exhibited by CFTR purified under conditions that retain associated lipids native to the membrane. It was found that CFTR purified together with phospholipids and cholesterol using amphipol: A8-35, exhibited higher rates of catalytic activity, phosphorylation dependent channel activation and potentiation by the therapeutic compound, ivacaftor, than did CFTR purified in detergent. The catalytic activity of phosphorylated CFTR detergent micelles was rescued by the addition of phospholipids plus cholesterol, but not by phospholipids alone, arguing for a specific role for cholesterol in modulating this function. In summary, these studies highlight the importance of lipid interactions in the intrinsic activities and pharmacological potentiation of CFTR.

摘要

最近利用冷冻电子显微镜技术解析的斑马鱼和人类囊性纤维化跨膜电导调节因子(CFTR)结构,为研究该蛋白阴离子通道门控机制提供了前所未有的线索。有趣的是,尽管基于生物膜通道活性测量做出了预测,但去污剂纯化、磷酸化和 ATP 结合的人源 CFTR 蛋白的结构并不能揭示稳定的开放传导途径。本研究检验了一个假设,即用于结构测定的去污剂溶解的 CFTR 蛋白的功能特性与在保留膜固有相关脂质的条件下纯化的 CFTR 所表现出的特性不同。结果发现,与在去污剂中纯化的 CFTR 相比,使用两性离子去污剂 A8-35 与磷脂和胆固醇一起纯化的 CFTR 表现出更高的催化活性、磷酸化依赖性通道激活以及治疗化合物 ivacaftor 的增强作用。添加磷脂加胆固醇可挽救磷酸化 CFTR 去污剂胶束的催化活性,但仅添加磷脂则不行,这表明胆固醇在调节该功能方面具有特定作用。总之,这些研究强调了脂质相互作用在 CFTR 的固有活性和药理学增强中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf5/6721619/e35e6ce09e1f/cells-08-00804-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf5/6721619/131ec0ca9998/cells-08-00804-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf5/6721619/84ae90a36972/cells-08-00804-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf5/6721619/56184cb4cafc/cells-08-00804-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf5/6721619/e35e6ce09e1f/cells-08-00804-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf5/6721619/131ec0ca9998/cells-08-00804-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf5/6721619/84ae90a36972/cells-08-00804-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf5/6721619/56184cb4cafc/cells-08-00804-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf5/6721619/e35e6ce09e1f/cells-08-00804-g004.jpg

相似文献

1
Cholesterol Interaction Directly Enhances Intrinsic Activity of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).胆固醇相互作用直接增强囊性纤维化跨膜电导调节剂(CFTR)的固有活性。
Cells. 2019 Jul 31;8(8):804. doi: 10.3390/cells8080804.
2
Molecular structure of the ATP-bound, phosphorylated human CFTR.ATP 结合磷酸化的人 CFTR 的分子结构。
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12757-12762. doi: 10.1073/pnas.1815287115. Epub 2018 Nov 20.
3
Functional characterization reveals that zebrafish CFTR prefers to occupy closed channel conformations.功能特征分析表明,斑马鱼 CFTR 更倾向于占据关闭的通道构象。
PLoS One. 2018 Dec 31;13(12):e0209862. doi: 10.1371/journal.pone.0209862. eCollection 2018.
4
Characterization of the adenosinetriphosphatase and transport activities of purified cystic fibrosis transmembrane conductance regulator.纯化的囊性纤维化跨膜传导调节因子的三磷酸腺苷酶及转运活性的特性分析
Biochemistry. 2004 Feb 3;43(4):1045-53. doi: 10.1021/bi035382a.
5
ATPase activity of the cystic fibrosis transmembrane conductance regulator.囊性纤维化跨膜传导调节因子的ATP酶活性
J Biol Chem. 1996 Nov 8;271(45):28463-8. doi: 10.1074/jbc.271.45.28463.
6
Purified cystic fibrosis transmembrane conductance regulator (CFTR) does not function as an ATP channel.纯化的囊性纤维化跨膜传导调节因子(CFTR)不具有ATP通道的功能。
J Biol Chem. 1996 May 17;271(20):11623-6. doi: 10.1074/jbc.271.20.11623.
7
Cryo-EM Visualization of an Active High Open Probability CFTR Anion Channel.冷冻电镜可视化活性高开放概率 CFTR 阴离子通道。
Biochemistry. 2018 Oct 30;57(43):6234-6246. doi: 10.1021/acs.biochem.8b00763. Epub 2018 Oct 16.
8
Coupling of ATP hydrolysis with channel gating by purified, reconstituted CFTR.纯化、重组的囊性纤维化跨膜传导调节因子(CFTR)将ATP水解与通道门控偶联。
J Bioenerg Biomembr. 1997 Oct;29(5):465-73. doi: 10.1023/a:1022435007193.
9
Walker mutations reveal loose relationship between catalytic and channel-gating activities of purified CFTR (cystic fibrosis transmembrane conductance regulator).沃克突变揭示了纯化的囊性纤维化跨膜传导调节因子(CFTR)的催化活性与通道门控活性之间的松散关系。
Biochemistry. 1999 Feb 2;38(5):1463-8. doi: 10.1021/bi982243y.
10
Conformational Variability in Ground-State CFTR Lipoprotein Particle Cryo-EM Ensembles.构象变异性在 CFTR 脂蛋白颗粒冷冻电镜集合体中的研究。
Int J Mol Sci. 2022 Aug 17;23(16):9248. doi: 10.3390/ijms23169248.

引用本文的文献

1
Case Study: Genetic and In Silico Analysis of Familial Pancreatitis.案例研究:家族性胰腺炎的基因与计算机模拟分析
Genes (Basel). 2025 May 20;16(5):603. doi: 10.3390/genes16050603.
2
Fatty acid abnormalities in cystic fibrosis-the missing link for a cure?囊性纤维化中的脂肪酸异常——治愈的关键环节缺失?
iScience. 2024 Oct 11;27(11):111153. doi: 10.1016/j.isci.2024.111153. eCollection 2024 Nov 15.
3
High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposing.在囊性纤维化患者来源的类器官中进行高通量功能测定可实现药物再利用。

本文引用的文献

1
Structural identification of a hotspot on CFTR for potentiation.CFTR 增强剂作用热点的结构鉴定。
Science. 2019 Jun 21;364(6446):1184-1188. doi: 10.1126/science.aaw7611.
2
Identifying the molecular target sites for CFTR potentiators GLPG1837 and VX-770.鉴定 CFTR 增效剂 GLPG1837 和 VX-770 的分子靶位。
J Gen Physiol. 2019 Jul 1;151(7):912-928. doi: 10.1085/jgp.201912360. Epub 2019 Jun 4.
3
Agonists that stimulate secretion promote the recruitment of CFTR into membrane lipid microdomains.激动剂刺激分泌促进 CFTR 向膜脂微区募集。
ERJ Open Res. 2023 Jan 30;9(1). doi: 10.1183/23120541.00495-2022. eCollection 2023 Jan.
4
Elexacaftor/Tezacaftor/Ivacaftor Accelerates Wound Repair in Cystic Fibrosis Airway Epithelium.依列卡福妥/替扎卡福妥/依伐卡托可加速囊性纤维化气道上皮的伤口修复。
J Pers Med. 2022 Sep 25;12(10):1577. doi: 10.3390/jpm12101577.
5
A protocol for identifying the binding sites of small molecules on the cystic fibrosis transmembrane conductance regulator (CFTR) protein.一种用于鉴定小分子在囊性纤维化跨膜传导调节因子(CFTR)蛋白上结合位点的方案。
STAR Protoc. 2022 Apr 7;3(2):101258. doi: 10.1016/j.xpro.2022.101258. eCollection 2022 Jun 17.
6
Alteration of Membrane Cholesterol Content Plays a Key Role in Regulation of Cystic Fibrosis Transmembrane Conductance Regulator Channel Activity.膜胆固醇含量的改变在囊性纤维化跨膜传导调节因子通道活性的调控中起关键作用。
Front Physiol. 2021 Jun 7;12:652513. doi: 10.3389/fphys.2021.652513. eCollection 2021.
7
Identification of binding sites for ivacaftor on the cystic fibrosis transmembrane conductance regulator.艾伐卡托在囊性纤维化跨膜传导调节因子上结合位点的鉴定
iScience. 2021 May 15;24(6):102542. doi: 10.1016/j.isci.2021.102542. eCollection 2021 Jun 25.
8
Phenotyping Rare CFTR Mutations Reveal Functional Expression Defects Restored by TRIKAFTA.罕见CFTR突变的表型分析揭示了TRIKAFTA可恢复的功能表达缺陷。
J Pers Med. 2021 Apr 15;11(4):301. doi: 10.3390/jpm11040301.
9
Is the ENaC Dysregulation in CF an Effect of Protein-Lipid Interaction in the Membranes?CF 中 ENaC 的功能失调是否是膜中蛋白-脂相互作用的结果?
Int J Mol Sci. 2021 Mar 8;22(5):2739. doi: 10.3390/ijms22052739.
10
Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator.依利卓(elexacaftor)作为矫正剂和增强剂的双重作用部分介导了依利卓(elexacaftor)联合泰比培南(tezacaftor)和 ivacaftor 对多种 II 类 CFTR 突变的挽救。
Eur Respir J. 2021 Jun 17;57(6). doi: 10.1183/13993003.02774-2020. Print 2021 Jun.
J Gen Physiol. 2019 Jun 3;151(6):834-849. doi: 10.1085/jgp.201812143. Epub 2019 May 2.
4
Molecular structure of the ATP-bound, phosphorylated human CFTR.ATP 结合磷酸化的人 CFTR 的分子结构。
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12757-12762. doi: 10.1073/pnas.1815287115. Epub 2018 Nov 20.
5
Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques.通过X射线晶体学和生物物理技术对具有免疫球蛋白折叠的糖蛋白进行表征
J Vis Exp. 2018 Jul 5(137):57750. doi: 10.3791/57750.
6
Conformational States of ABC Transporter MsbA in a Lipid Environment Investigated by Small-Angle Scattering Using Stealth Carrier Nanodiscs.利用隐匿载体纳米盘的小角散射研究 ABC 转运蛋白 MsbA 在脂质环境中的构象状态。
Structure. 2018 Aug 7;26(8):1072-1079.e4. doi: 10.1016/j.str.2018.05.007. Epub 2018 Jun 21.
7
Lipophilicity of the Cystic Fibrosis Drug, Ivacaftor (VX-770), and Its Destabilizing Effect on the Major CF-causing Mutation: F508del.囊性纤维化药物 Ivacaftor(VX-770)的亲脂性及其对主要 CF 致病突变 F508del 的失稳作用。
Mol Pharmacol. 2018 Aug;94(2):917-925. doi: 10.1124/mol.118.112177. Epub 2018 Jun 14.
8
Structural basis of small-molecule inhibition of human multidrug transporter ABCG2.小分子抑制人多药转运体 ABCG2 的结构基础。
Nat Struct Mol Biol. 2018 Apr;25(4):333-340. doi: 10.1038/s41594-018-0049-1. Epub 2018 Apr 2.
9
Structural mechanisms of CFTR function and dysfunction.CFTR 功能和失能的结构机制。
J Gen Physiol. 2018 Apr 2;150(4):539-570. doi: 10.1085/jgp.201711946. Epub 2018 Mar 26.
10
Sites associated with Kalydeco binding on human Cystic Fibrosis Transmembrane Conductance Regulator revealed by Hydrogen/Deuterium Exchange.通过氢/氘交换揭示人类囊性纤维化跨膜电导调节蛋白与 Kalydeco 结合的相关位点。
Sci Rep. 2018 Mar 16;8(1):4664. doi: 10.1038/s41598-018-22959-6.